Viewing Study NCT01223235


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2026-02-22 @ 6:45 PM
Study NCT ID: NCT01223235
Status: COMPLETED
Last Update Posted: 2018-06-12
First Post: 2010-10-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
Sponsor:
Organization: